Broken Heart: A Rare and Potentially Fatal Complication of Endomyocardial Biopsy

1Cooper University Hospital, Camden, NJ, USA

2Department of Medicine, Cooper University Hospital, Camden, NJ, USA

*Corresponding author:

Maya Ignaszewski, MD, Cardiology Fellow, Cooper University Hospital, Camden, NJ, USA, E-mail: mayaigna@gmail.com

How to cite this article:

Ignaszewski M (2019) Broken Heart: A Rare and Potentially Fatal Complication of Endomyocardial Biopsy. Cardiol Cases Syst Rev. 1:004.

Copyright © Ignaszewski M, et al.

Received: June 14, 2019; Accepted: August 01, 2019; Published: August 05, 2019

Keywords

Endomyocardial biopsy, Cardiac sarcoidosis, Right ventricle perforation

Abbreviations

EMB: Endomyocardial biopsy

Endomyocardial biopsy (EMB) is an established invasive procedure in which samples of myocardial tissue are obtained for both diagnostic and therapeutic purposes. Generally, it is used for cardiac allograft rejection surveillance and evaluation of restrictive and dilated cardiomyopathies [1]. Class I indications for performing EMB include unexplained new-onset heart failure of less than 2 weeks duration with hemodynamic compromise, unexplained new-onset heart failure of 2 weeks to 3 months duration with dilated left ventricle and new ventricular arrhythmias or conduction disturbances [2]. However, the role of EMB in diagnosis of infiltrative cardiac disease remains controversial and must be approached on a case-by-case basis. Ultimately, indications largely depend on instances when the anticipated prognostic and diagnostic yield outweighs the procedural risk.

We present a 62-year-old female with past medical history of Hodgkin's lymphoma, hypothyroidism and hypertension who presented with multiple syncopal episodes. Work-up revealed sinus bradycardia on electrocardiogram and a 4.7-second pause with complete heart block on Holter monitor. CT thorax showed enlarged right axillary lymph nodes and calcification within the right breast concerning for new metastatic spread of prior treated Hodgkin's lymphoma. Cardiac MRI revealed delayed enhancement at the junction of the apical septal and apical inferior segments, suspicious for sarcoidosis, metastasis or giant cell arteritis. EMB was performed for diagnostic evaluation and to help guide future treatment plan. This was complicated by right ventricle perforation and pericardial tamponade necessitating left thoracotomy with pericardiectomy, pericardiocentesis, manual cardiac massage and internal cardiac defibrillation. Hepatorrhaphy of a sustained left hepatic lobe laceration was performed and hema-glue was applied to the left ventricle, right ventricle and epicardial surfaces with subsequent vascular repair of the left internal mammillary artery. The patient was eventually stabilized and made a full recovery. Unfortunately, EMB contained only extracardiac tissue and the patient was treated for presumptive sarcoidosis after underlying metastatic disease was ruled out via lymph node biopsy.

Life-threatening complications of EMB, which may include cardiac tamponade or right ventricular perforation, are postulated to occur in less than 0.8% of cases [3-5]. According to a large retrospective study, EMB was complicated by cardiac tamponade requiring pericardiocentesis 0.12% of the time [4]. Although generally regarded as a safe procedure, our case highlights a clinical scenario in which the patient suffered a rare and near fatal event. When considering EMB, clinicians must be certain that the diagnostic and therapeutic benefits of this fundamental procedure outweigh the potentially catastrophic complications.

Acknowledgements

None.

Conflict of Interest Disclosure

No conflicts of interest. No financial disclosures.

References

  1. From AM, Maleszewski JJ, Rihal CS (2011) Current status of endomyocardial biopsy. Mayo Clin Proc 86: 1095-1102.
  2. Cooper Leslie T, Baughman Kenneth L, Feldman Arthur M, Andrea Frustaci, Mariell Jessup, et al. (2007) The role of endomyocardial biopsy in the management of cardiovascular disease. Circulation 116: 2216-2233.
  3. Chimenti Cristina, Frustaci Andrea (2013) Contribution and risks of left ventricular endomyocardial biopsy in patients with cardiomyopathies. Circulation 128: 1531-1541.
  4. Holzmann M, Nicko A, Kühl U, Noutsias M, Poller W, et al. (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: A retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118: 1722-1728.
  5. Yilmaz Ali, Kindermann Ingrid, Kindermann Michael, Felix Mahfoud, Christian Ukena, et al. (2010) Comparative evaluation of left and right ventricular endomyocardial biopsy. Circulation 122: 900-909.

Open Access Declaration

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source of content.